ENTA
NASDAQ
$13.42
Enanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $21.17 (+57.75%)
Market Cap
$384M
Free Cash Flow Yield
-2.50%
Beta (5Y)
0.94
Price Chart
Valuation
Market Cap$384M
Forward P/E44.05
P/S5.51
P/B3.40
Profitability
Total Revenue (TTM)$54M
Gross Profit (TTM)$69M
EBITDA-$118M
Profit Margin-76.3%
Operating Margin-69.1%
EPS-$5.54
Financial Health
Free Cash Flow Yield-2.50%
Growth & Risk
EPS 5Y CAGR+8.56%
Revenue 5Y CAGR-10.49%
FCF 5Y CAGR-24.94%
Beta (5Y)0.94
Sharpe Ratio0.92